BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37562365)

  • 21. Prenatal diagnosis of sporadic neurofibromatosis type 1 (NF1) by RNA and DNA analysis of a splicing mutation.
    Ars E; Kruyer H; Gaona A; Serra E; Lázaro C; Estivill X
    Prenat Diagn; 1999 Aug; 19(8):739-42. PubMed ID: 10451518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-yield identification of pathogenic NF1 variants by skin fibroblast transcriptome screening after apparently normal diagnostic DNA testing.
    Douben HCW; Nellist M; van Unen L; Elfferich P; Kasteleijn E; Hoogeveen-Westerveld M; Louwen J; van Veghel-Plandsoen M; de Valk W; Saris JJ; Hendriks F; Korpershoek E; Hoefsloot LH; van Vliet M; van Bever Y; van de Laar I; Aten E; Lachmeijer AMA; Taal W; van den Bersselaar L; Schuurmans J; Oostenbrink R; van Minkelen R; van Ierland Y; van Ham TJ
    Hum Mutat; 2022 Dec; 43(12):2130-2140. PubMed ID: 36251260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NF1 exon 22 analysis of individuals with the clinical diagnosis of neurofibromatosis type 1.
    Muram-Zborovski TM; Vaughn CP; Viskochil DH; Hanson H; Mao R; Stevenson DA
    Am J Med Genet A; 2010 Aug; 152A(8):1973-8. PubMed ID: 20602485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurofibromatosis type 1 (NF1): a protein truncation assay yielding identification of mutations in 73% of patients.
    Park VM; Pivnick EK
    J Med Genet; 1998 Oct; 35(10):813-20. PubMed ID: 9783703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The R1947X mutation of NF1 causing autosomal dominant neurofibromatosis type 1 in a Chinese family.
    Yang Q; Huang C; Yang X; Feng Y; Wang Q; Liu M
    J Genet Genomics; 2008 Feb; 35(2):73-6. PubMed ID: 18407053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fifty-four novel mutations in the NF1 gene and integrated analyses of the mutations that modulate splicing.
    Xu W; Yang X; Hu X; Li S
    Int J Mol Med; 2014 Jul; 34(1):53-60. PubMed ID: 24789688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RT-PCR splicing analysis of the NF1 open reading frame.
    Thomson SA; Wallace MR
    Hum Genet; 2002 May; 110(5):495-502. PubMed ID: 12073021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the potential pathogenicity of missense mutations identified in the GTPase-activating protein (GAP)-related domain of the neurofibromatosis type-1 (NF1) gene.
    Thomas L; Richards M; Mort M; Dunlop E; Cooper DN; Upadhyaya M
    Hum Mutat; 2012 Dec; 33(12):1687-96. PubMed ID: 22807134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NF1 mutation rather than individual genetic variability is the main determinant of the NF1-transcriptional profile of mutations affecting splicing.
    Pros E; Larriba S; López E; Ravella A; Gili ML; Kruyer H; Valls J; Serra E; Lázaro C
    Hum Mutat; 2006 Nov; 27(11):1104-14. PubMed ID: 16937374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome.
    Ekvall S; Sjörs K; Jonzon A; Vihinen M; Annerén G; Bondeson ML
    Am J Med Genet A; 2014 Mar; 164A(3):579-87. PubMed ID: 24357598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel mutations involving the NF1 gene coding sequence in neurofibromatosis type 1 patients from Taiwan.
    Liu MT; Su JS; Huang CY; Tsai SF
    J Hum Genet; 2003; 48(10):545-549. PubMed ID: 14513407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
    Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
    Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance Evaluation of SpliceAI for the Prediction of Splicing of
    Ha C; Kim JW; Jang JH
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a Novel
    Xu G; Li M; Niu Y; Huang X; Li Y; Tang G; Long S; Zhao H; Jiang H
    Biomed Res Int; 2019; 2019():2721357. PubMed ID: 31886188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel mutation in NF1 gene of patient with Neurofibromatosis type 1: A case report and functional study.
    Zhang T; Jia C; Dong Z; Li C; Lu W
    Mol Genet Genomic Med; 2021 May; 9(5):e1643. PubMed ID: 33764694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pathological splicing mutation c.6792C>G in NF1 exon 37 causes a change of tenancy between antagonistic splicing factors.
    Skoko N; Baralle M; Buratti E; Baralle FE
    FEBS Lett; 2008 Jun; 582(15):2231-6. PubMed ID: 18503770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A novel indel NF1 mutation identified in a patient with neurofibromatosis type 1].
    Zhu T; Huang S; Wu J; Wang C; Yang T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Jun; 32(3):318-22. PubMed ID: 26037340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patient.
    Perren A; Wiesli P; Schmid S; Montani M; Schmitt A; Schmid C; Moch H; Komminoth P
    Am J Surg Pathol; 2006 Aug; 30(8):1047-51. PubMed ID: 16861979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neurofibromin - protein structure and cellular functions in the context of neurofibromatosis type I pathogenesis].
    Abramowicz A; Gos M
    Postepy Hig Med Dosw (Online); 2015 Dec; 69():1331-48. PubMed ID: 26671924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel mutation in NF1 is associated with diverse intra-familial phenotypic variation and astrocytoma in a Chinese family.
    Banerjee S; Dai Y; Liang S; Chen H; Wang Y; Tang L; Wu J; Huang H
    J Clin Neurosci; 2016 Sep; 31():182-4. PubMed ID: 27234610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.